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Background
DNA vaccines are a good option to generate a desired
antigen using the cellular machinery of the vaccinated
subject. This kind of vaccine can induce both of the
humoral and cellular immune response, and show high
stability and easy working, as well as offer a low-cost pro-
duction. and safety for immune compromised patients
[1]. However, some disadvantages, such as the low trans-
fection rate and low immunogenicity, makes necessary
the use of multiple doses [2,3]. Therefore, several studies
have been conducted trying to increase the immune
response generated by the DNA vaccines. Sacharomyces
boulardii, a probiotic yeast that is capable to increase the
host immune response [4], was not previously evaluated
as an adjuvant for DNA vaccines. Thereby, in the present
study we evaluated the S. boulardii capacity to increase
the humoral response of mice using DNA vaccines
against a fragment of the leptospiral antigen LigAcloned
in the mammalian expression plasmid pTARGET [4,5].
Material and methods
Four to six month-old Female BALB/c mice were sepa-
rated into 2 groups of 12 animals each. Group 1 (G1,
control) were fed with antimicrobial-free ration; group 2
(G2) with the same ration containing 108cfu.g-1 of S. bou-
lardii, 14 days before the first immunization, for adapta-
tion, and during all the experiment. The immunization
protocol consisted in 3 doses (days 0, 14 and 21) of
100 µg of the pTARGET/ligAni plasmid injected intra-
muscularly. Blood samples were collected from the retro
eye venous plexus of the animals on days 0, 13, 20 and 27
for the humoral immune response evaluation of each
immunization through indirect ELISA, using recombi-
nant LigAni (5 µg.mL-1) as antigen and serum dilutions
1:30 in PBS-T.ELISA units were calculated by dividing
the mean absorbance of each group by the mean absor-
bance of the day 0. The student’s test-t was performed to
determine significant differences (p < 0.05) between the
groups.
Results and conclusions
Sera from G2 has shown ELISA units statistically higher
than the sera from G1 after the second (p < 0.0001) and
third immunization (p = 0.0264). In addition, there was
nosignificant difference between the second and third
immunizations of G2. This way, the results indicate that
using S. boulardii as adjuvant, only two immunizations
are sufficient to obtain an adequate immune response.
Therefore, the S. boulardii probiotic was able to
enhance the humoral immune response to a DNA vac-
cine against leptospirosis in mice.
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